The feasibility of a metalic stent for Esophageal benign stricture after endoscopic submucosal dissection for esophageal squamous cell neoplasms

The feasibility of a metalic stent for Esophageal benign stricture after endoscopic submucosal dissection for esophageal squamous cell neoplasms - Metalic stent for esophageal benign stricture

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004249

Enrollment

Registered

2010-09-22

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial esophageal squamous cell neoplasms

Interventions

Place a metalic stent for esophageal benign stricture.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. age; 20-80 years-old 2. with esophageal benign stricture after endoscopic submucosal dissection for esophageal squamous cell neoplasms. 3. with re-stricture after endoscopic balloon dilation for esophageal benign stricture. 4. Performance status: 0, 1. 5. with or without multiple stricture. 6. without organ failure. 7. without serious complication. 8. obtained written informed consent.

Exclusion criteria

Exclusion criteria: 1. post operative status of esophagectomy. 2. with overt infection or inflammation of esophagus. 3. inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
Incidence of the complication related with metalic stent placement.	—

Secondary

Measure	Time frame
1) Incidence of the re-stricture after stent removal 2) Duration of stricture-free or symptom-free period	—

Countries

Japan

Contacts

Public ContactHirohisa Machida

Osaka City University Graduate School of Medicine Department of Gastroenterology

06-6645-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026